A61K 49 - Preparations for testing in vivo

Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2011
11/09/2011	CN101496906B Lipid nano granule containing magnetic resonance contrast agent as well as preparation method and use thereof
11/09/2011	CN101420985B Test agent for diagnosing dyspepsia
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8052669 Methods and devices for delivery of compositions to conduits
11/08/2011	CA2153692C Recombinant anti-vla4 antibody molecules
11/03/2011	WO2011137459A1 Dosage forms of elinogrel and methods of injectable administration thereof
11/03/2011	WO2011137319A2 Stabilized fibronectin domain compositions, methods and uses
11/03/2011	WO2011136645A1 Fused cyclooctyne compounds and their use in metal-free click reactions
11/03/2011	WO2011136500A2 Multi-core-shell nanoparticles
11/03/2011	WO2011136336A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging of digestive tract
11/03/2011	WO2011135369A1 Diagnostic reagents
11/03/2011	WO2011135275A1 Method and microbubbles for detecting atherosclerotic plaque
11/03/2011	WO2011135101A2 Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy
11/03/2011	WO2011134060A1 Anti-icam-1 single domain antibody and uses thereof
11/03/2011	WO2011080570A3 Extended release pharmaceutical composition comprising linezolid and process for preparing the same
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110268747 Stxbp1 as psychiatric biomarker in murine model system and their uses
11/03/2011	US20110268663 Intravascular contrast agents
11/03/2011	US20110268662 Functionalized nanoceria composition for ophthalmic treatment
11/03/2011	US20110268661 Fluorescent fusion polypeptides and methods of use
11/03/2011	US20110268660 Method for detecting dysplasia
11/03/2011	US20110268659 High shear application in drug delivery
11/03/2011	US20110268658 Polymer-agent conjugates, particles, compositions, and related methods of use
11/03/2011	US20110268656 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
11/03/2011	US20110268654 Compositions and methods for delivering a substance to a biological target
11/03/2011	US20110268653 Compositions and Methods Related to Acid Stable Lipid Nanospheres
11/03/2011	CA2800565A1 Anti-icam-1 single domain antibody and uses thereof
11/02/2011	EP2381966A2 Pdgf-r binders
11/02/2011	EP1960002B1 Aqueous dispersions of superparamagnetic single domain particles production and use thereof for diagnosis and therapy
11/02/2011	EP1931735B1 High-purity texaphyrin metal complexes
11/02/2011	EP1755659B1 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
11/02/2011	EP1503805B1 Lyophilized edible food incorporating a marker
11/02/2011	EP1461449B1 System for monitoring bacterial tumor treatment
11/02/2011	CN102231991A Active particles for bio-analytical applications and methods for their preparation
11/02/2011	CN102228702A Method for preparing dendrimer mediated gold-silver alloy nanoparticles
11/02/2011	CN102228701A Dual tumor targeted gadopentetate dimeglumine nanoliposome and its preparation method
11/02/2011	CN102228700A Method for constructing insulin resistance animal model
11/02/2011	CN102228699A Method and purpose for constructing traditional Chinese medicine (TCM) spleen deficiency syndrome AIDS monkey model
11/02/2011	CN102228690A Application of antifolic in constructing mouse model with neural tube defects (NTDs)
11/02/2011	CN102228442A Star-like macromolecule nanometer microsphere and preparation method and application thereof
11/02/2011	CN101885692B 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof
11/01/2011	US8048906 Optically pure and enriched isomers of chelating ligands and contrast agents
11/01/2011	US8048417 Anti-human tenascin monoclonal antibody
11/01/2011	US8048407 In situ gelling self-reactive materials for embolization
11/01/2011	US8048405 Radioactive mixture and manufacturing method thereof
11/01/2011	CA2505677C Method and apparatus for time resolved optical imaging of biological tissues as part of animals
11/01/2011	CA2203622C Compounds, pharmaceutical composition and diagnostic device comprising them and their use
11/01/2011	CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide
10/2011
10/27/2011	WO2011133925A2 Targeted and light-activated cytosolic drug delivery
10/27/2011	WO2011133773A2 Compositions and methods for leukocyte-targeting multi-valent imaging probes
10/27/2011	WO2011133685A2 Nanoparticle targeting to ischemia for imaging and therapy
10/27/2011	WO2011133653A1 Inhibitors of arginase and their therapeutic applications
10/27/2011	WO2011131912A1 Magneto-optical nano-objects for cancer detection
10/27/2011	WO2011131896A2 Peptide derivatives, preparation thereof and uses thereof as vectors
10/27/2011	WO2011100829A8 Bifunctional chelating agents
10/27/2011	WO2011069082A3 Red blood cell-mimetic particles and methods for making and use thereof
10/27/2011	WO2011066182A3 Socs3 inhibition promotes cns neuron regeneration
10/27/2011	WO2011059262A3 Uses of apoptotic cell-targeting peptides, label substances and liposomes containing a therapeutic agent for preventing, treating or therapeutically diagnosing apoptosis-related diseases
10/27/2011	US20110264027 B ring reduced-d ring oxidized tetrapyrollic photosensitizers for photodynamic therapy and tumor imaging
10/27/2011	US20110263975 Fluorescent probes having a polymeric backbone
10/27/2011	US20110263968 Drug-Enhanced Neurofeedback
10/27/2011	US20110263691 Methods concerning ppar delta and antagonists thereof
10/27/2011	US20110262366 Compounds for targeting endothelial cells, compositions containing the same and methods for their use
10/27/2011	US20110262365 Methods of diagnosing hypersensitivity to a female reproductive hormone and treating medical conditions associated with same
10/27/2011	US20110262364 Fluorescent Particles Comprising Nanoscale ZnO Layer and Exhibiting Cell-Specific Toxicity
10/27/2011	US20110262363 Glucose biosensor system coupled with an anti-inflammatory module and methods for using the same
10/27/2011	US20110262362 Methods for treating obesity
10/27/2011	US20110262361 effective new drug target for the treatment of tuberculosis
10/27/2011	US20110262360 Compositions Comprising Enzyme-Cleavable Phenol-Modified Opioid Prodrugs and Inhibitors Thereof
10/27/2011	US20110262359 Compositions comprising enzyme-cleavable prodrugs of active agents and inhibitors thereof
10/27/2011	US20110262358 Molecular marker for cancer stem cell
10/27/2011	US20110262357 Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy
10/27/2011	US20110262356 Active Particles for Bio-Analytical Applications and Methods for Preparation Thereof
10/27/2011	US20110262355 Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereof
10/27/2011	US20110262354 Cyanine-containing compounds for cancer imaging and treatment
10/27/2011	US20110262353 Muteins of hngal and related proteins with affinity for a given target
10/27/2011	US20110262347 Methods and compositions for enhanced delivery of compounds
10/26/2011	EP2380595A1 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
10/26/2011	EP2379118A2 Nanoparticle contrast agents for diagnostic imaging
10/26/2011	EP2010152B1 Magnetic nanoparticles compositions and uses thereof
10/26/2011	CN102225866A Preparation method for ferrite nano-particles
10/26/2011	CN102225210A Preparation method and application of long afterglow luminescent nano particles with phospholipid as surface modification
10/26/2011	CN101519387B Thiophenylamine derivative two-photon biological developing material
10/25/2011	US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011	US8043604 Ultrasonography using time- and temperature-sensitive variable adhesion coupling gels
10/25/2011	US8043603 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
10/25/2011	US8043602 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology
10/25/2011	CA2493109C Automated dynamic pressure-responsive hyperpolarized gas dispensing systems, and associated methods and computer program products
10/25/2011	CA2302228C Sterilized 5-aminolevulinic acid
10/20/2011	WO2011130658A1 Custom designed microbubble contrast agents and techniques of ultrasound delivery optimized for nucleic acid delivery to alter gene expression
10/20/2011	WO2011129427A1 Diagnostic agent and therapeutic agent for cancer
10/20/2011	WO2011128931A1 Pulpitis diagnostic marker and pulpitis diagnostic system
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257106 Polymer Stabilized Neuropeptides
10/20/2011	US20110256068 Contrast media compositions
10/20/2011	US20110256067 Contrast agents endowed with high relaxivity
10/20/2011	US20110256066 Method for preparing engineered mg doped ferrite superparamagnetic nano particle exhibiting ac magnetic induction heating at high temperature and mg doped ferrite superparamagnetic nano particles engineered by the method
10/20/2011	US20110256065 Non-Isotopic Detection of Osteoblastic Activity In Vivo Using Modified Bisphosphonates
10/20/2011	US20110256064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
10/20/2011	US20110256063 Mex3c regulation and target to control obesity and diabetes

1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 354